Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.
The transforming gene of a human lung carcinoma-derived cell line, Hs242, has been cloned in biologically active form, and identified as c-bas/has (otherwise known as c-Ha-ras). The genetic lesion responsible for the transforming activity of the Hs242 oncogene has been localized to a point mutation in the second exon which results in the substitution of leucine for glutamine as amino acid 61 of the predicted protein. No changes were observed in the first exon, the region of c-bas/has in which a point mutation is responsible for activation of the T24 and EJ bladder carcinoma oncogenes.
D001483:Base Sequence; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D003001:Cloning, Molecular; D005973:Glutamine / Q000235:genetics; D006801:Humans; D007930:Leucine / Q000235:genetics; D008175:Lung Neoplasms; D009154:Mutation; D009857:Oncogenes; D000090063:Proto-Oncogene Mas; D001749:Urinary Bladder Neoplasms / Q000235:genetics
C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D005973:Glutamine; D007930:Leucine